| Unknown | Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions Bioequivalence | Phase 1 | 2024-01-09 |
| Unknown | Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunt Bioequivalence | Phase 1 | 2023-06-24 |
| Completed | Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Und Bioequivalence | Phase 1 | 2023-06-16 |
| Completed | Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunt Bioequivalence | Phase 1 | 2022-12-28 |
| Completed | Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Bioequivalence | Phase 1 | 2022-11-19 |
| Completed | Bioequivalence Study of Two Formulations of Tablets Ramipril 10 mg in Healthy Volunteers Under Fasting Conditi Bioequivalence | Phase 1 | 2022-06-17 |
| Completed | Bioequivalence Study of Two Formulations of Tablets Aceclofenac 100 mg in Healthy Volunteers Under Fasting Con Bioequivalence | Phase 1 | 2022-04-15 |
| Completed | Bioequivalence Study of Two Formulations of Lisinopril Tablet 20 mg in Healthy Volunteers Under Fasting Condit Bioequivalence | Phase 1 | 2021-10-06 |
| Completed | Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting Condit Bioequivalence | Phase 1 | 2021-06-05 |
| Unknown | Bioequivalence Study of Two Formulations of Sildenafil Tablet 100 mg in Healthy Male Volunteers Under Fasting Bioequivalence | Phase 1 | 2021-05-10 |
| Unknown | Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Cond Bioequivalence | Phase 1 | 2021-04-10 |
| Unknown | Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 10 mg in Healthy Male Volunteers in Fasting Co Bioequivalence | Phase 1 | 2021-02-13 |
| Unknown | Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 20 mg in Healthy Male Volunteers Under Fed Con Bioequivalence | Phase 1 | 2021-01-30 |
| Unknown | A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Sing Bioequivalence | Phase 1 | 2019-10-31 |
| Completed | Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy A Bioequivalence | Phase 1 | 2019-07-26 |
| Completed | The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Admin Bioequivalence | Phase 1 | 2019-07-11 |
| Completed | The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Admini Bioequivalence | Phase 1 | 2019-05-06 |
| Completed | Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers Bioequivalence | Phase 1 | 2019-05-03 |
| Completed | Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers Bioequivalence | Phase 1 | 2019-03-23 |
| Completed | A Bioequivalence Study of Two Formulations Lamotrigine 100 mg Tablets and Lamictal 100 mg Tablets in Healthy A Healthy Adults | Phase 1 | 2019-03-23 |
| Completed | Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair®, 5 m Healthy Adults | Phase 1 | 2019-03-23 |
| Completed | Bioequivalence Study of Sotalol, Tablets, 160 mg (Pharmtechnology LLC, Belarus), and Sotalex ®, Tablets, 160 m Bioequivalence | Phase 1 | 2019-01-09 |
| Completed | Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augm Bioequivalence | Phase 1 | 2018-09-21 |
| Completed | Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fastin Bioequivalence | Phase 1 | 2018-09-07 |
| Completed | Bioequivalence Study of Clavamox, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (Pharmtechnology LLC, Bela Bioequivalence | Phase 1 | 2018-07-28 |
| Completed | Bioequivalence Study of Ibuprofen D, Oral Suspension, 200 mg/5ml and Nurofen®, Oral Suspension 100 mg/5 ml in Healthy | Phase 1 | 2018-06-11 |
| Completed | A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy Healthy | Phase 1 | 2018-02-16 |